April 30 (Reuters) - Genocea Biosciences Inc GNCA.O :
* GENOCEA PROVIDES CORPORATE UPDATE, INCLUDING FIRST-QUARTER
2019
FINANCIAL RESULTS
* GENOCEA BIOSCIENCES INC - ANTICIPATES PRESENTING FIRST
GEN-009
IMMUNOGENICITY DATA AT ASCO 2019
* GENOCEA BIOSCIENCES - EXPECTS EXISTING CASH AND CASH
EQUIVALENTS
ARE SUFFICIENT TO SUPPORT ITS OPERATIONS INTO Q1 OF 2020
* GENOCEA BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.15
Source text for Eikon: ID:nGNXc6Dhkt
Further company coverage: GNCA.O
((Briefs@thomsonreuters.com;))